CBO Says Diagnostics Would Spike Bipartisan Breakthrough Device Coverage Bill’s Cost

By Christian Robles / October 10, 2025 at 5:01 PM

SAN DIEGO -- The Congressional Budget Office (CBO) reportedly has estimated that adding diagnostics to a bipartisan bill expediting Medicare coverage for FDA-designated and authorized breakthrough devices would balloon the legislation’s cost by at least threefold.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.